{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:24:09Z","timestamp":1788456249929,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University","award":["Z2024YY003"],"award-info":[{"award-number":["Z2024YY003"]}]},{"name":"National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University","award":["Z2024YY003"],"award-info":[{"award-number":["Z2024YY003"]}]},{"name":"National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University","award":["Z2024YY003"],"award-info":[{"award-number":["Z2024YY003"]}]},{"name":"1\u00b73\u00b75 project for disciplines of excellence\u2013Clinical Research Fund, West China Hospital, Sichuan University","award":["2024HXFH015"],"award-info":[{"award-number":["2024HXFH015"]}]},{"name":"1\u00b73\u00b75 project for disciplines of excellence\u2013Clinical Research Fund, West China Hospital, Sichuan University","award":["2024HXFH015"],"award-info":[{"award-number":["2024HXFH015"]}]},{"name":"1\u00b73\u00b75 project for disciplines of excellence\u2013Clinical Research Fund, West China Hospital, Sichuan University","award":["2024HXFH015"],"award-info":[{"award-number":["2024HXFH015"]}]},{"name":"National Key Clinical Specialties Construction Program"},{"name":"Research Project established by Chinese Pharmaceutical Association Hospital Phamacy Department","award":["CPA-Z05-ZC-2024002"],"award-info":[{"award-number":["CPA-Z05-ZC-2024002"]}]},{"name":"Research Project established by Chinese Pharmaceutical Association Hospital Phamacy Department","award":["CPA-Z05-ZC-2024002"],"award-info":[{"award-number":["CPA-Z05-ZC-2024002"]}]},{"name":"Research Project established by Chinese Pharmaceutical Association Hospital Phamacy Department","award":["CPA-Z05-ZC-2024002"],"award-info":[{"award-number":["CPA-Z05-ZC-2024002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"DOI":"10.1186\/s12877-024-05630-w","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T04:58:55Z","timestamp":1735275535000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The prevalence and factors associated with potentially inappropriate medications in Chinese older outpatients with heart failure"],"prefix":"10.1186","volume":"24","author":[{"given":"Ying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"issue":"2","key":"5630_CR1","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/jgs.17018","volume":"69","author":"NJ Ailabouni","year":"2021","unstructured":"Ailabouni NJ, Marcum ZA, Schmader KE, Gray SL. Medication Use Quality and Safety in older adults: 2019 update. J Am Geriatr Soc. 2021;69(2):336\u201341.","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"5630_CR2","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1177\/1060028019853069","volume":"53","author":"XX Xing","year":"2019","unstructured":"Xing XX, Zhu C, Liang HY, Wang K, Chu YQ, Zhao LB, et al. Associations between potentially inappropriate medications and adverse Health outcomes in the Elderly: a systematic review and Meta-analysis. Ann Pharmacother. 2019;53(10):1005\u201319.","journal-title":"Ann Pharmacother"},{"issue":"13","key":"5630_CR3","doi-asserted-by":"publisher","first-page":"3808","DOI":"10.3390\/jcm11133808","volume":"11","author":"R D\u00edez","year":"2022","unstructured":"D\u00edez R, Cadenas R, Susperregui J, Sahag\u00fan AM, Fern\u00e1ndez N, Garc\u00eda JJ, et al. Potentially inappropriate medication and polypharmacy in nursing home residents: a cross-sectional study. J Clin Med. 2022;11(13):3808.","journal-title":"J Clin Med"},{"issue":"6","key":"5630_CR4","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00228-018-2446-0","volume":"74","author":"FR Motter","year":"2018","unstructured":"Motter FR, Fritzen JS, Hilmer SN, Paniz \u00c9V, Paniz VMV. Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria. Eur J Clin Pharmacol. 2018;74(6):679\u2013700.","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"5630_CR5","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.japh.2022.04.008","volume":"62","author":"G Schiavo","year":"2022","unstructured":"Schiavo G, Forgerini M, Lucchetta RC, Silva GO, Mastroianni PDC. Cost of adverse drug events related to potentially inappropriate medication use: a systematic review. J Am Pharm Assoc. 2022;62(5):1463\u201376.","journal-title":"J Am Pharm Assoc"},{"issue":"9","key":"5630_CR6","doi-asserted-by":"publisher","first-page":"e8621","DOI":"10.1016\/j.jamda.2016.06.011","volume":"17","author":"L Morin","year":"2016","unstructured":"Morin L, Laroche ML, Texier G, Johnell K. Prevalence of potentially inappropriate medication use in older adults living in nursing homes: a systematic review. J Am Med Dir Assoc. 2016;17(9):e8621\u20139.","journal-title":"J Am Med Dir Assoc"},{"issue":"8","key":"5630_CR7","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1590\/1413-81232021268.05672020","volume":"26","author":"MFDS Praxedes","year":"2021","unstructured":"Praxedes MFDS, Pereira GCDS, Lima CFDM, Santos DBD, Berhends JS. Prescribing potentially inappropriate medications for the elderly according to Beers Criteria: systematic review. Cien Saude Colet. 2021;26(8):3209\u201319.","journal-title":"Cien Saude Colet"},{"key":"5630_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2147\/DHPS.S303101","volume":"13","author":"H Alshammari","year":"2021","unstructured":"Alshammari H, Al-Saeed E, Ahmed Z, Aslanpour Z. Reviewing potentially inappropriate medication in hospitalized patients over 65 using Explicit Criteria: a systematic literature review. Drug Healthc Patient Saf. 2021;13:183\u2013210.","journal-title":"Drug Healthc Patient Saf"},{"issue":"3","key":"5630_CR9","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/ajag.13046","volume":"41","author":"G Schiavo","year":"2022","unstructured":"Schiavo G, Forgerini M, Lucchetta RC, Mastroianni PC. A comprehensive look at explicit screening tools for potentially inappropriate medication: a systematic scoping review. Australas J Ageing. 2022;41(3):357\u201382.","journal-title":"Australas J Ageing"},{"issue":"4","key":"5630_CR10","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.15767","volume":"67","author":"The 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2019","unstructured":"The 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674\u201394.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"5630_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.hfc.2017.02.001","volume":"13","author":"K Dharmarajan","year":"2017","unstructured":"Dharmarajan K, Rich MW. Epidemiology, pathophysiology, and prognosis of Heart failure in older adults. Heart Fail Clin. 2017;13(3):417\u201326.","journal-title":"Heart Fail Clin"},{"issue":"4","key":"5630_CR12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s10741-012-9363-6","volume":"18","author":"P Abete","year":"2013","unstructured":"Abete P, Testa G, Della-Morte D, Gargiulo G, Galizia G, de Santis D, et al. Treatment for chronic heart failure in the elderly: current practice and problems. Heart Fail Rev. 2013;18(4):529\u201351.","journal-title":"Heart Fail Rev"},{"issue":"9","key":"5630_CR13","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.cjca.2016.05.005","volume":"32","author":"H Butrous","year":"2016","unstructured":"Butrous H, Hummel SL. Heart failure in older adults. Can J Cardiol. 2016;32(9):1140\u20137.","journal-title":"Can J Cardiol"},{"issue":"6","key":"5630_CR14","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/ijpp.12651","volume":"28","author":"M Zahwe","year":"2020","unstructured":"Zahwe M, Skouri H, Rachidi S, Khoury M, Noureddine S, Isma\u2019eel H, et al. Potentially inappropriate medications in elderly patients with heart failure: Beers Criteria-based study. Int J Pharm Pract. 2020;28(6):652\u20139.","journal-title":"Int J Pharm Pract"},{"issue":"6","key":"5630_CR15","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.cardfail.2021.11.014","volume":"28","author":"D Jaber","year":"2022","unstructured":"Jaber D, Vargas F, Nguyen L, Ringel J, Zarzuela K, Musse M, et al. Prescriptions for potentially inappropriate medications from the Beers Criteria among older adults hospitalized for heart failure. J Card Fail. 2022;28(6):906\u201315.","journal-title":"J Card Fail"},{"key":"5630_CR16","doi-asserted-by":"publisher","first-page":"998769","DOI":"10.3389\/fpubh.2022.998769","volume":"10","author":"Q Jiang","year":"2022","unstructured":"Jiang Q, Feng Q, Editorial. Aging and health in China. Front Public Health. 2022;10:998769.","journal-title":"Front Public Health"},{"issue":"6","key":"5630_CR17","doi-asserted-by":"publisher","first-page":"e027852","DOI":"10.1161\/JAHA.122.027852","volume":"12","author":"T Yan","year":"2023","unstructured":"Yan T, Zhu S, Yin X, Xie C, Xue J, Zhu M, et al. Burden, Trends, and inequalities of heart failure globally, 1990 to 2019: a secondary analysis based on the global burden of Disease 2019 study. J Am Heart Assoc. 2023;12(6):e027852.","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"5630_CR18","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.jacc.2019.12.059","volume":"75","author":"GM Felker","year":"2020","unstructured":"Felker GM, Ellison DH, Mullens W, Cox ZL, Testani JM. Diuretic therapy for patients with heart failure: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(10):1178\u201395.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"5630_CR19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.hfc.2017.02.006","volume":"13","author":"DA Sica","year":"2017","unstructured":"Sica DA, Gehr TWB, Frishman WH. Use of diuretics in the treatment of Heart failure in older adults. Heart Fail Clin. 2017;13(3):503\u201312.","journal-title":"Heart Fail Clin"},{"issue":"2\u20133","key":"5630_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3121\/cmr.2020.1548","volume":"18","author":"D Soodi","year":"2020","unstructured":"Soodi D, VanWormer JJ, Rezkalla SH. Aspirin in primary Prevention of Cardiovascular events. Clin Med Res. 2020;18(2\u20133):89\u201394.","journal-title":"Clin Med Res"},{"issue":"10","key":"5630_CR21","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","volume":"74","author":"DK Arnett","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC\/AHA Guideline on the primary Prevention of Cardiovascular Disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines. J Am Coll Cardiol. 2019;74(10):e177\u2013232.","journal-title":"J Am Coll Cardiol"},{"key":"5630_CR22","doi-asserted-by":"publisher","first-page":"114147","DOI":"10.1016\/j.bcp.2020.114147","volume":"180","author":"S Bindu","year":"2020","unstructured":"Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective. Biochem Pharmacol. 2020;180:114147.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"5630_CR23","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/JCN.0000000000000719","volume":"36","author":"R Gharzeddine","year":"2021","unstructured":"Gharzeddine R, McCarthy MM, Yu G, Dickson VV. Insomnia and insomnia symptoms in persons with heart failure: an integrative review. J Cardiovasc Nurs. 2021;36(4):374\u201384.","journal-title":"J Cardiovasc Nurs"},{"issue":"12","key":"5630_CR24","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.3390\/healthcare9121724","volume":"9","author":"T Okui","year":"2021","unstructured":"Okui T, Park J, Hirata A, Nakashima N. Trends in the prescription of benzodiazepine receptor agonists from 2009 to 2020: a retrospective study using Electronic Healthcare Record Data of a University Hospital in Japan. Healthcare. 2021;9(12):1724.","journal-title":"Healthcare"},{"issue":"6","key":"5630_CR25","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1111\/jgs.15842","volume":"67","author":"AB Minns","year":"2019","unstructured":"Minns AB, Kreshak A, Dunlay R, Castillo E, Clark RF, Killeen J, et al. Prevalence of benzodiazepine and benzodiazepine-receptor agonist use in a geriatric Emergency Department Population. J Am Geriatr Soc. 2019;67(6):1309\u201311.","journal-title":"J Am Geriatr Soc"},{"key":"5630_CR26","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2147\/DHPS.S14955","volume":"2","author":"AY Avidan","year":"2010","unstructured":"Avidan AY, Palmer LA, Doan JF, Baran RW. Insomnia medication use and the probability of an accidental event in an older adult population. Drug Healthc Patient Saf. 2010;2:225\u201332.","journal-title":"Drug Healthc Patient Saf"},{"issue":"4","key":"5630_CR27","doi-asserted-by":"publisher","first-page":"E678","DOI":"10.9778\/cmajo.20180121","volume":"6","author":"DL Weir","year":"2018","unstructured":"Weir DL, Samanani S, Gilani F, Jess E, Eurich DT. Benzodiazepine receptor agonist dispensations in Alberta: a population-based descriptive study. CMAJ Open. 2018;6(4):E678\u201384.","journal-title":"CMAJ Open"},{"issue":"5","key":"5630_CR28","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1517\/14740338.3.5.485","volume":"3","author":"S Madhusoodanan","year":"2004","unstructured":"Madhusoodanan S, Bogunovic OJ. Safety of benzodiazepines in the geriatric population. Expert Opin Drug Saf. 2004;3(5):485\u201393.","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"5630_CR29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/ageing\/afx167","volume":"47","author":"N Treves","year":"2018","unstructured":"Treves N, Perlman A, Kolenberg Geron L, Asaly A, Matok I. Z-drugs and risk for falls and fractures in older adults-a systematic review and meta-analysis. Age Ageing. 2018;47(2):201\u20138.","journal-title":"Age Ageing"},{"issue":"10","key":"5630_CR30","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/phar.2170","volume":"38","author":"RC Lucchetta","year":"2018","unstructured":"Lucchetta RC, da Mata BPM, Mastroianni PC. Association between Development of Dementia and Use of benzodiazepines: a systematic review and Meta-analysis. Pharmacotherapy. 2018;38(10):1010\u201320.","journal-title":"Pharmacotherapy"},{"issue":"7","key":"5630_CR31","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/arclin\/acx120","volume":"33","author":"SF Crowe","year":"2018","unstructured":"Crowe SF, Stranks EK. The residual medium and long-term Cognitive effects of Benzodiazepine Use: an updated Meta-analysis. Arch Clin Neuropsychol. 2018;33(7):901\u201311.","journal-title":"Arch Clin Neuropsychol"},{"issue":"1","key":"5630_CR32","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.2146\/ajhp160381","volume":"75","author":"JD Picton","year":"2018","unstructured":"Picton JD, Marino AB, Nealy KL. Benzodiazepine use and cognitive decline in the elderly. Am J Health Syst Pharm. 2018;75(1):e6\u201312.","journal-title":"Am J Health Syst Pharm"},{"issue":"5","key":"5630_CR33","first-page":"339","volume":"64","author":"K Pottie","year":"2018","unstructured":"Pottie K, Thompson W, Davies S, Grenier J, Sadowski CA, Welch V, et al. Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline. Can Fam Physician. 2018;64(5):339\u201351.","journal-title":"Can Fam Physician"},{"issue":"1","key":"5630_CR34","first-page":"43","volume":"129","author":"JY Lee","year":"2019","unstructured":"Lee JY, Farrell B, Holbrook AM. Deprescribing benzodiazepine receptor agonists taken for insomnia: a review and key messages from practice guidelines. Pol Arch Intern Med. 2019;129(1):43\u20139.","journal-title":"Pol Arch Intern Med"},{"key":"5630_CR35","doi-asserted-by":"crossref","unstructured":"Markota M, Rummans TA, Bostwick JM, Lapid MI. Benzodiazepine Use in Older Adults: Dangers, Management, and Alternative Therapies. Mayo Clin Proc. 2016;91(11):1632\u20131639.","DOI":"10.1016\/j.mayocp.2016.07.024"},{"issue":"6","key":"5630_CR36","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jchf.2019.03.005","volume":"7","author":"MA Carlisle","year":"2019","unstructured":"Carlisle MA, Fudim M, DeVore AD, Piccini JP. Heart failure and Atrial Fibrillation, like fire and fury. JACC Heart Fail. 2019;7(6):447\u201356.","journal-title":"JACC Heart Fail"},{"issue":"10","key":"5630_CR37","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883\u201391.","journal-title":"N Engl J Med"},{"issue":"12","key":"5630_CR38","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12):1139\u201351.","journal-title":"N Engl J Med"},{"issue":"2","key":"5630_CR39","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000516075","volume":"68","author":"AS Bhagavathula","year":"2022","unstructured":"Bhagavathula AS, Gebreyohannes EA, Fialova D. Prevalence of polypharmacy and risks of potentially inappropriate medication use in the older Population in a developing country: a systematic review and Meta-analysis. Gerontology. 2022;68(2):136\u201345.","journal-title":"Gerontology"},{"issue":"1","key":"5630_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/13814788.2017.1288211","volume":"23","author":"H Storms","year":"2017","unstructured":"Storms H, Marquet K, Aertgeerts B, Claes N. Prevalence of inappropriate medication use in residential long-term care facilities for the elderly: a systematic review. Eur J Gen Pract. 2017;23(1):69\u201377.","journal-title":"Eur J Gen Pract"},{"issue":"8","key":"5630_CR41","doi-asserted-by":"publisher","first-page":"e2326910","DOI":"10.1001\/jamanetworkopen.2023.26910","volume":"6","author":"F Tian","year":"2023","unstructured":"Tian F, Chen Z, Zeng Y, Feng Q, Chen X. Prevalence of Use of potentially inappropriate medications among older adults Worldwide: a systematic review and Meta-analysis. JAMA Netw Open. 2023;6(8):e2326910.","journal-title":"JAMA Netw Open"},{"issue":"10","key":"5630_CR42","doi-asserted-by":"publisher","first-page":"e0206120","DOI":"10.1371\/journal.pone.0206120","volume":"13","author":"YL Niriayo","year":"2018","unstructured":"Niriayo YL, Kumela K, Kassa TD, Angamo MT. Drug therapy problems and contributing factors in the management of heart failure patients in Jimma University Specialized Hospital, Southwest Ethiopia. PLoS ONE. 2018;13(10):e0206120.","journal-title":"PLoS ONE"},{"issue":"702","key":"5630_CR43","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.3399\/bjgp21X714245","volume":"71","author":"Y Wu","year":"2020","unstructured":"Wu Y, Zhu W, He X, Xue R, Liang W, Wei F, et al. Influence of polypharmacy on patients with heart failure with preserved ejection fraction: a retrospective analysis on adverse outcomes in the TOPCAT trial. Br J Gen Pract. 2020;71(702):e62\u201370.","journal-title":"Br J Gen Pract"},{"issue":"1","key":"5630_CR44","doi-asserted-by":"publisher","first-page":"e012240","DOI":"10.1136\/bmjopen-2016-012240","volume":"7","author":"A Marciniak","year":"2017","unstructured":"Marciniak A, Glover K, Sharma R. Cohort profile: prevalence of valvular heart disease in community patients with suspected heart failure in UK. BMJ Open. 2017;7(1):e012240.","journal-title":"BMJ Open"},{"issue":"1","key":"5630_CR45","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ccep.2020.11.007","volume":"13","author":"B John","year":"2021","unstructured":"John B, Lau CP. Atrial fibrillation in Valvular Heart Disease. Card Electrophysiol Clin. 2021;13(1):113\u201322.","journal-title":"Card Electrophysiol Clin"},{"key":"5630_CR46","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2147\/DHPS.S255893","volume":"13","author":"A Whitman","year":"2021","unstructured":"Whitman A, Erdeljac P, Jones C, Pillarella N, Nightingale G. Managing polypharmacy in older adults with Cancer across different Healthcare settings. Drug Healthc Patient Saf. 2021;13:101\u201316.","journal-title":"Drug Healthc Patient Saf"},{"issue":"4","key":"5630_CR47","doi-asserted-by":"publisher","first-page":"e28732","DOI":"10.1002\/jmv.28732","volume":"95","author":"F Tian","year":"2023","unstructured":"Tian F, Chen Z, Feng Q. Nirmatrelvir-ritonavir compared with other antiviral drugs for the treatment of COVID-19 patients: a systematic review and meta-analysis. J Med Virol. 2023;95(4):e28732.","journal-title":"J Med Virol"},{"issue":"2","key":"5630_CR48","doi-asserted-by":"publisher","first-page":"106870","DOI":"10.1016\/j.ijantimicag.2023.106870","volume":"62","author":"F Tian","year":"2023","unstructured":"Tian F, Feng Q, Chen Z. Efficacy and safety of Molnupiravir Treatment for COVID-19: a systematic review and Meta-analysis of Randomized controlled trials. Int J Antimicrob Agents. 2023;62(2):106870.","journal-title":"Int J Antimicrob Agents"},{"key":"5630_CR49","doi-asserted-by":"publisher","first-page":"777655","DOI":"10.3389\/fphar.2021.777655","volume":"12","author":"DA Rodrigues","year":"2022","unstructured":"Rodrigues DA, Pl\u00e1cido AI, Mateos-Campos R, Figueiras A, Herdeiro MT, Roque F. Effectiveness of interventions to reduce potentially inappropriate medication in older patients: a systematic review. Front Pharmacol. 2022;12:777655.","journal-title":"Front Pharmacol"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-024-05630-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-024-05630-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-024-05630-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T06:02:17Z","timestamp":1735279337000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-024-05630-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5630"],"URL":"https:\/\/doi.org\/10.1186\/s12877-024-05630-w","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,27]]},"assertion":[{"value":"14 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the West China Hospital Research Ethics Board. All procedures performed in this study conform to the standards of the 1964 Helsinki Declaration and subsequent relevant ethics. Due to the nature of this retrospective study and the preserved anonymity of patients, a waiver of informed consent was obtained by the West China Hospital Research Ethics Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1040"}}